What is the appropriate next diagnostic and treatment approach for a patient with a positive stool glutamate dehydrogenase (GDH) test for Clostridioides difficile?

Diagnostic Approach for Positive Stool GDH Test

A positive GDH test alone does not confirm Clostridioides difficile infection and requires immediate reflex testing with toxin A/B enzyme immunoassay (EIA), followed by PCR/NAAT arbitration if the toxin test is negative. 1

Understanding the GDH Test Result

• GDH is a highly sensitive screening test (89-93%) that detects the presence of C. difficile bacteria but cannot distinguish between toxigenic and non-toxigenic strains, nor between active infection and asymptomatic colonization 1, 2
• Approximately 20% of C. difficile strains are non-toxigenic and incapable of causing disease, which is why confirmatory testing is essential 3
• GDH positivity alone should never trigger treatment decisions, as this leads to overtreatment of colonization rather than true infection 3

Required Next Steps in the Diagnostic Algorithm

Step 1: Immediate Toxin A/B EIA Testing

• Perform toxin A/B enzyme immunoassay on the same GDH-positive specimen as the second step in the multistep algorithm 4, 1
• Select a toxin test with sensitivity in the upper range reported in the literature (laboratories should choose high-performing assays) 4
• If toxin EIA is positive: This confirms active C. difficile infection requiring antimicrobial treatment 1, 5
• If toxin EIA is negative: Proceed immediately to Step 2 for arbitration 1

Step 2: PCR/NAAT Arbitration for Discordant Results

• When GDH is positive but toxin is negative, perform NAAT/PCR testing to arbitrate the discordant result 4, 1
• PCR has 95.7% sensitivity and 100% specificity when used as an arbitration tool in this context 1
• This three-step algorithm (GDH → toxin → NAAT if discordant) provides results for 85-92% of samples on the day of receipt 1

Clinical Interpretation Based on Final Results

GDH-Positive/Toxin-Positive (Regardless of PCR):

• These patients have true C. difficile infection requiring treatment 1, 5
• Toxin-positive patients have significantly worse outcomes: 7.6% complication rate, 8.4% mortality, and longer duration of diarrhea 1
• Initiate antimicrobial therapy immediately (see treatment section below) 1

GDH-Positive/Toxin-Negative/PCR-Positive:

• These patients likely represent colonization rather than active infection, with minimal complication rates (0% in the largest study) and 0.6% mortality 1
• Treatment decisions should be based on clinical severity rather than test results alone in this scenario 1
• Consider empiric treatment only if the patient has severe illness: high fever (>38.5°C), significant leukocytosis (WBC >15,000), rising creatinine, or severe diarrhea 1
• In the absence of severe illness, search for alternative causes of diarrhea rather than treating for C. difficile 1

GDH-Positive/Toxin-Negative/PCR-Negative:

• This effectively rules out C. difficile infection with a negative predictive value of 99-100% 3
• Do not initiate or continue C. difficile-directed antibiotic therapy 3
• This result pattern represents non-toxigenic C. difficile colonization that does not require treatment 3
• Discontinue contact precautions if they were implemented based on initial GDH screening 3

Clinical Context Required Before Testing

Verify appropriate patient selection criteria were met:

• Patient must have ≥3 unformed stools in 24 hours with no obvious alternative explanation 4, 1
• No laxative use within the preceding 48 hours 1
• Only liquid or soft stools that conform to the shape of the container should have been tested 1
• Recent antibiotic exposure, hospitalization within 3 months, or hospital stay >72 hours increases suspicion 1

Treatment Considerations for Confirmed Infection

For toxin-positive patients or severely ill PCR-positive/toxin-negative patients:

• Oral vancomycin 125 mg four times daily is appropriate for initial therapy 1
• Fidaxomicin is preferred over vancomycin when available 6
• Metronidazole is not adequate treatment by current standards 6

Critical Pitfalls to Avoid

• Never treat based on GDH positivity alone without completing the full diagnostic algorithm 1, 3
• Never repeat testing within 7 days during the same diarrheal episode—this has only 2% diagnostic yield and increases false positives 4, 1
• Never perform test of cure after treatment, as >60% remain positive despite clinical resolution 1
• Never test infants ≤12 months of age due to high asymptomatic carriage rates 4, 1
• Never use NAAT/PCR alone as a stand-alone test in endemic settings without the multistep algorithm, as this leads to overdiagnosis of colonization 1

Special Circumstances

• In patients with ileus who cannot produce stool, perirectal swabs tested by PCR demonstrate 95.7% sensitivity and 100% specificity and may be used as an alternative 1, 3
• The same multistep algorithm should be applied to perirectal swabs as for stool specimens 1